513 related articles for article (PubMed ID: 18322249)
1. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
[TBL] [Abstract][Full Text] [Related]
2. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
4. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography.
Devreese K; Peerlinck K; Arnout J; Hoylaerts MF
Thromb Haemost; 2009 Jan; 101(1):185-96. PubMed ID: 19132207
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
6. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
Galli M; Ruggeri L; Barbui T
Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
9. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
Solymoss S; Nguyen KT
Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
[TBL] [Abstract][Full Text] [Related]
10. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies.
Espinola RG; Pierangeli SS; Gharavi AE; Harris EN
Thromb Haemost; 2002 Mar; 87(3):518-22. PubMed ID: 11916085
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation.
Martinuzzo ME; Maclouf J; Carreras LO; Lévy-Toledano S
Thromb Haemost; 1993 Oct; 70(4):667-71. PubMed ID: 8115993
[TBL] [Abstract][Full Text] [Related]
14. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
15. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
17. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to beta 2-glycoprotein I inhibit phospholipid dependent coagulation reactions.
Brandt JT
Thromb Haemost; 1993 Oct; 70(4):598-602. PubMed ID: 8115986
[TBL] [Abstract][Full Text] [Related]
19. Platelets significantly modify procoagulant activities in haemophilia A.
Wartiovaara-Kautto U; Joutsi-Korhonen L; Ilveskero S; Armstrong E; Lassila R
Haemophilia; 2011 Sep; 17(5):743-51. PubMed ID: 21682825
[TBL] [Abstract][Full Text] [Related]
20. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
Tsakiris DA; Settas L; Makris PE; Marbet GA
J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
